novel therapy

1 abstract

Abstract
The impact of a cancer-specific novel therapy adjustment (NTA) in Medicare value-based care programs: A simulation exercise.
Org: US Oncology Network, Dallas, Txinno Bioscience, McKesson, Denver, CO,